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Sphingolipids are regulators of mitochondria-mediated cell death in higher eukaryotes. Here, we investigate how changes in
sphingolipid metabolism and downstream intermediates of sphingosine impinge on mitochondrial function. We found in yeast
that within the sphingolipid degradation pathway, the production via Dpl1p and degradation via Hfd1p of hexadecenal are
critical for mitochondrial function and cell death. Genetic interventions, which favor hexadecenal accumulation, diminish
oxygen consumption rates and increase reactive oxygen species production and mitochondrial fragmentation and vice versa.
The location of the hexadecenal-degrading enzyme Hfd1p in punctuate structures all along the mitochondrial network depends
on a functional ERMES (endoplasmic reticulum-mitochondria encounter structure) complex, indicating that modulation of
hexadecenal levels at speciﬁc ER-mitochondria contact sites might be an important trigger of cell death. This is further
supported by the ﬁnding that externally added hexadecenal or the absence of Hfd1p enhances cell death caused by ectopic
expression of the human Bax protein. Finally, the induction of the sphingolipid degradation pathway upon stress is controlled
by the Hog1p MAP kinase. Therefore, the stress-regulated modulation of sphingolipid degradation might be a conserved way to
induce cell death in eukaryotic organisms.
1. Introduction
Sphingolipids are specialized bioactive lipid molecules found
in the membranes of all eukaryotic cells. They have critical
functions in the control of cell growth, senescence, diﬀerenti-
ation, and programmed cell death. Diﬀerent intermediates of
sphingolipid pathways can have opposing eﬀects on cell
signaling. Therefore, imbalances in sphingolipid metabolism
can deregulate key cellular processes and contribute to
human disorders [1–3]. A critical cellular homeostasis path-
way regulated by sphingolipids is mitochondria-mediated
apoptosis [4]. In this process, multiple pathways converge
on mitochondria and induce mitochondrial outer membrane
permeabilization (MOMP). MOMP causes the release of
proteins from the mitochondrial intermembrane space into
the cytosol, where they execute the programmed cell death
via the caspase cascade in higher eukaryotes. Therefore,
MOMP is considered the initial irreversible trigger of mito-
chondrial apoptosis [5]. This death decision needs to be
tightly controlled and depends on the interplay of several
pro- and antiapoptotic members of the Bcl-2 family [6, 7].
Some Bcl-2 protein members such as Bax have to gain access
to mitochondria in response to apoptotic stimulation, as they
are normally cytosolic proteins [8, 9]. During apoptotic acti-
vation, Bax structural conformation is altered in a regulated
manner, which facilitates its insertion into the outer
mitochondrial membrane followed by dimerization and the
formation of higher order oligomeric pores to induce MOMP
[10, 11]. Speciﬁc sphingolipid levels at mitochondria are
known to regulate the entry into mitochondrial apoptosis
[4, 12]. Ceramide has been identiﬁed as a prodeath molecule,
as it can induce apoptosis when applied externally [13], and
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the regulation of ceramide biosynthesis and degradation is
important for the entry into the intrinsic apoptotic pathway
[14–16]. However, recent studies point to important
proapoptotic functions for metabolites of the sphingolipid
degradation pathway, such as sphingosine-1-phosphate (S1-
P) or hexadecenal [17, 18]. S1-P and hexadecenal are eﬃcient
inducers of Bax-mediated apoptosis and MOMP in vitro
[17]. Since sphingolipid metabolism takes place in the ER,
the regulated production and transfer of sphingolipid metab-
olites to mitochondria might be an important, but yet unex-
plored, upstream event in the initiation of cell death [19].
Despite their simplicity, yeast cells are an informative
model to understand the regulation of programmed cell
death [20, 21]. Importantly, yeast undergoes MOMP, cyto-
chrome c release, and mitochondrial fragmentation in
response to apoptotic stimuli [22–24], as well as upon the
heterologous expression of the human apoptosis executer
Bax [25, 26]. As for higher eukaryotes, also in yeast, our
information about the eﬀect of sphingolipid metabolism on
mitochondrial function and death is limited to ceramide
levels [27, 28]. The lack of enzyme functions leading to cer-
amide production has been shown to decrease programmed
cell death in response to acetic acid in yeast [29]. The
enzymes involved are Isc1p and Lag1p, which contribute to
ceramide formation by the breakdown of complex sphingoli-
pids or by de novo synthesis, respectively. However, the
recent identiﬁcation of the precise enzymatic steps involved
in the degradation of sphingolipids and the formation of
the key intermediates S1-P and hexadecenal in yeast [30]
has enabled us to study the eﬀect of this metabolic pathway
on mitochondrial-mediated cell death. We show here that
the key enzyme in this pathway, the hexadecenal metaboliz-
ing Hfd1p dehydrogenase, has a stress-regulated function
associated with mitochondria, which might be decisive for
the entry into mitochondrial cell death.
2. Materials and Methods
2.1. Yeast Strains and Plasmids. A complete list of yeast
strains used in this work can be found in Table 1. Constitu-
tive expression of Hfd1-GFP was obtained by cloning full
length HFD1 into the yeast Gateway vector pAG426-GPD-
ccdB-GFP [31]. Fusion of full length OM14 with dsRed was
performed in yeast Gateway vector pAG415-GPD-ccdB-
dsRed [31]. Galactose inducible overexpression of Dpl1p
was achieved by cloning full length DPL1 into yeast Gateway
vector pAG426-GAL1p-ccdB-HA [31]. Plasmids pCM189-
Bax and pCM184-Bcl-xL for Tetoﬀ-controlled Bcl-2 member
protein expression were a kind gift from S. Manon [32].
GFP-Ybh3 fusion protein expression was achieved from plas-
mid pUG36-GFP-YBH3 (a kind gift from F. Madeo [33]).
For the galactose inducible expression of a Mmm1-
mCherry fusion protein, plasmid pAG413-GAL1p-MMM1-
mCherry was used (a kind gift from W. Prinz [34]).
2.2. Growth Conditions. Yeast strains were grown at 28°C in
yeast extract peptone containing 2% dextrose (YPD) or 2%
galactose (YPGal) for agar plate assays. Synthetic dextrose
(SD) or galactose (SGal) media contained 0.67% yeast
nitrogen base, 50mM succinic acid (pH5.5), and 2% of
the respective energy source. According to the auxotro-
phies of each strain, methionine (10mg/l), histidine
(10mg/l), leucine (10mg/l), or uracil (25mg/l) were added.
As indicated, growth media were supplemented with men-
adione, valinomycin, or NaCl from appropriate stocks in
DMSO (menadione) or water (valinomycin, NaCl). Yeast
strains transformed with Bax- or Bcl-xL-expression plas-
mids were pregrown in the presence of 10μg/ml doxycy-
cline (Sigma), and protein expression was induced by
switching cells to doxycycline-free medium. For sensitivity
assays with externally added sphingolipid metabolic inter-
mediates, serial dilutions of the cells were treated in syn-
thetic liquid medium with the indicated doses of the
compounds from DMSO stock solutions and then plated
onto YPD agar plates. Palmitic acid, hexadecenoic acid,
and sphingosine-1-phosphate were purchased from Sigma;
hexadecenal was purchased from Avanti Polar Lipids. For
quantitative colony assays, fresh overnight yeast cultures
were diluted in triplicate to OD600 = 0.1 and allowed to
grow for 24h on the indicated media. Alternatively, for
the hexadecenal toxicity assays, fresh overnight cultures in
SD medium were adjusted to the same OD600 and then
treated with the indicated concentrations of hexadecenal
for 2 h. The number of colony-forming units was then
determined by plating the cultures onto YPD agar plates
at appropriate dilutions.
2.3. Reverse Transcriptase Assays. Total RNA was isolated by
acid phenol extraction from yeast cells grown in the indicated
conditions. RNA samples were digested with DNaseI and
puriﬁed with the RNeasy Mini kit (Qiagen). A total of 5μg
of RNA was converted into DNA using the SuperScript III
First-Strand cDNA Synthesis kit (Invitrogen). The amount
of DNA was determined with the indicated gene-speciﬁc
primers by quantitative PCR in real time using the EvaGreen
qPCR Master Mix (Biotium) on an Applied Biosystems 7500
sequence detection system. The ACT1 gene was used as a ref-
erence. Relative expression levels were calculated in triplicate
from three independent cDNA samples. Primer sequences
are available upon request.
2.4. Microscopy. Mitochondria were visualized with Mito-
Tracker Red CMXRos (Invitrogen). Cells were incubated
with 1μM MitoTracker dye for 60min, washed once, and
ﬁnally resuspended in fresh culture medium. Cells were
observed on a Leica confocal microscope TCS SP8 using
the following excitation and emission wavelengths: GFP
(excitation 488nm; emission 509nm), mCherry (excitation
587 nm; emission 610nm), dsRed (excitation 560 nm; emis-
sion 592 nm), and MitoTracker Red (excitation 578 nm;
emission 600nm).
2.5. ROS Determination. Exponential cell culture aliquots
upon the indicated growth conditions were incubated
for 30min with 2′,7′-dichlorodihydroﬂuorescein diacetate
(Sigma) at a ﬁnal concentration of 10μM. The cells were
washed with water and resuspended in 1ml of 50mM Tris/
HCl pH7.5. After the addition of 10μl of chloroform and
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5μl of 0.1% SDS, cell extracts were prepared by rigorous agi-
tation with glass beads. Fluorescence was quantiﬁed in the
supernatant in a microplate reader at 492nm excitation and
525nm emission wavelengths and normalized for the ﬂuo-
rescence of the same number of mock-treated cells.
2.6. Measurement of Oxygen Consumption. For measure-
ments of respiration rates, yeast cells were grown to exponen-
tial phase in synthetic galactose-containing medium, washed
with water, and ﬁnally resuspended at the same OD in 40mM
NaPO4 pH7.4 with 1% glucose. Oxygen consumption was
Table 1: Yeast strains used in this study.
Name Relevant genotype Source
BY4741 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 EUROSCARF
BY4741 hfd1 BY4741 with hfd1Δ::KanMX EUROSCARF
BY4741 faa1 BY4741 with faa1Δ::KanMX EUROSCARF
BY4741 faa4 BY4741 with faa4Δ::KanMX EUROSCARF
BY4741 dpl1 BY4741 with dpl1Δ::KanMX EUROSCARF
BY4741 fzo1 BY4741 with fzo1Δ::KanMX EUROSCARF
BY4741 dnm1 BY4741 with dnm1Δ::KanMX EUROSCARF
BY4741 ﬁs1 BY4741 with ﬁs1Δ::KanMX EUROSCARF
BY4741 hog1 BY4741 with hog1Δ::KanMX EUROSCARF
BY4741 om14 BY4741 with om14Δ::KanMX EUROSCARF
BY4741 mcr1 BY4741 with mcr1Δ::KanMX EUROSCARF
BY4741 rdl1 BY4741 with rdl1Δ::KanMX EUROSCARF
BY4741 mdm10 BY4741 with mdm10Δ::KanMX EUROSCARF
BY4741 mdm12 BY4741 with mdm12Δ::KanMX EUROSCARF
BY4741 ybh3 BY4741 with ybh3Δ::KanMX EUROSCARF
BY4741 msn2msn4 BY4741 with msn2Δ::Nat msn4Δ::KanMX E. de Nadal
BY4741 Hfd1-GFP
Om14-dsRed
BY4741 with plasmids pAG426-GPD-HFD1-GFP (URA3) + pAG415-GPD-OM14-dsRed This study
BY4741 GAL1-ccdB-HA BY4741 with plasmid pAG426-GAL1p-ccdB-HA (URA3) This study
BY4741 GAL1-DPL1-HA BY4741 with plasmid pAG426-GAL1p-DPL1-HA (URA3) This study
hfd1 GAL1-ccdB-HA BY4741 hfd1Δ::KanMX with plasmid pAG426-GAL1p-ccdB-HA (URA3) This study
hfd1 GAL1-DPL1-HA BY4741 hfd1Δ::KanMX with plasmid pAG426-GAL1p-DPL1-HA (URA3) This study
W303-1A MATa; ade2-1; his3-11,-15; leu2,3-112; ura3-1; trp1 R. Rothstein
W303-1A Bax W303-1A with plasmid pCM189-Bax (TetOﬀ-Bax-c-myc, URA3) This study
W303-1A Bcl-xL W303-1A with plasmid pCM184-Bcl-xL (TetOﬀ-Bcl-xL-c-myc, TRP1) This study
W303-1A pCM189 W303-1A with plasmid pCM189 This study
W303-1A pCM184 W303-1A with plasmid pCM184 This study
BY4741 Bax BY4741 with plasmid pCM189-Bax (TetOﬀ-Bax-c-myc, URA3) This study
hfd1 Bax BY4741 hfd1Δ::KanMX with plasmid pCM189-Bax (TetOﬀ-Bax-c-myc, URA3) This study
hog1 Bax BY4741 hog1Δ::KanMX with plasmid pCM189-Bax (TetOﬀ-Bax-c-myc, URA3) This study
BY4741 pCM189 BY4741 with plasmid pCM189 This study
hfd1 pCM189 BY4741 hfd1Δ::KanMX with plasmid pCM189 This study
hog1 pCM189 BY4741 hog1Δ::KanMX with plasmid pCM189 This study
BY4741 Ybh3-GFP BY4741 with plasmid pUG36-GFP-YBH3 (URA3) This study
BY4741 Hfd1-GFP
Mmm1-mCherry
BY4741 with plasmids pAG426-GPD-HFD1-GFP (URA3) + pAG413-GAL1-MMM1-mCherry
(HIS3)
This study
mdm10 Hfd1-GFP BY4741 mdm10Δ::KanMX with plasmid pAG426-GPD-HFD1-GFP (URA3) This study
mdm12 Hfd1-GFP BY4741 mdm12Δ::KanMX with plasmid pAG426-GPD-HFD1-GFP (URA3) This study
mmm1 Hfd1-GFP BY4741 mmm1Δ::KanMX with plasmid pAG426-GPD-HFD1-GFP (URA3) This study
BY4741 mt-GFP BY4741 with plasmid pVT100U-mtGFP (URA3)
B.
Westermann
dnm1 mt-GFP BY4741 dnm1Δ::KanMX with plasmid pVT100U-mtGFP (URA3) This study
ﬁs1 mt-GFP BY4741 ﬁs1Δ::KanMX with plasmid pVT100U-mtGFP (URA3) This study
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then quantiﬁed in intact cells using a Mitocell S200 Respi-
rometry System (Strathkelvin Instruments) with a Clarke
type oxygen electrode. Oxygen consumption rates were
determined from at least three independent yeast cultures
for each strain background.
2.7. Statistical Analysis. Student’s t-test was performed to
compare the mean values between two diﬀerent condi-
tions or strains. A P value < 0.05 was considered statistically
signiﬁcant.
3. Results and Discussion
3.1. The Sphingolipid Degradation Pathway Regulates
Mitochondrial Function. It has been previously shown that
salt stress causes a profound change in mitochondrial activity
[35, 36]. Certain outer mitochondrial membrane proteins
such as Hfd1p, Om14p, Rdl1p, or Mcr1p seem to speciﬁcally
accumulate under these conditions at the organelle [35].
Om14p is a mitochondrial receptor for ribosomes with a
function in the cotranslational import of mitochondrial
proteins [37], Rdl1p is a putative mitochondrial thiosulfate
sulfurtransferase [38], while Mcr1p is a mitochondrial
NADH-cytochrome b5 reductase with a known function in
cellular ROS homeostasis [39]. We tested whether the expres-
sion of the corresponding nuclear genes was regulated upon
stress. All four genes were several fold upregulated upon both
salt and oxidative stress (Figure 1(a)). Further inspection of
the promoter regions of the four genes revealed that only
OM14, RDL1, and MCR1 contained several classical stress
response elements (STRE; Figure 1(b)). Indeed, the stress-
dependent transcriptional control of the three genes was lost
in the absence of the STRE-binding activators Msn2p/Msn4p
or the stress-activated MAP kinase Hog1p (Figure 1(c)). An
important function of the modulation of mitochondrial
activity during salt stress is the maintenance of ROS homeo-
stasis [36]. The ROS production was quantitatively assessed
in the respective yeast mutant strains upon normal growth
and salt or oxidative challenge. We found that the absence
of Hfd1p or Rdl1p caused a major ROS imbalance
(Figure 1(d)). We further investigated the role of Hfd1p in
the stress-regulated control of mitochondrial function.
HFD1 encodes a fatty aldehyde dehydrogenase, which
catalyzes the conversion of hexadecenal to hexadecenoic acid
in the sphingosine-1-phosphate (S1-P) degradation pathway
[30]. Sphingolipids are well-known inducers of programmed
cell death in higher eukaryotes and mitochondrial dysfunc-
tion in yeast [4, 27]. We wanted to determine whether down-
stream metabolites resulting from sphingolipid degradation
were able to modulate mitochondrial function in yeast
(Figure 2(a)). We found that genetic interruption of the path-
way upstream of hexadecenal formation in the dpl1Δmutant
increased oxygen consumption rates of whole yeast cells. A
block after hexadecenal formation in the hfd1Δ or faa1Δ
mutants decreased oxygen consumption (Figure 2(b)). This
result was further conﬁrmed by a decreased ROS production
in the dpl1Δmutant upon stress as opposed to the previously
shown overproduction of ROS in the hfd1Δ strain
(Figure 2(c)). These data suggested that the hexadecenal-
metabolizing enzyme Hfd1p had a function in modulating
mitochondrial activity and cellular ROS levels. We next
determined the subcellular localization of Hfd1p and found
that the enzyme localized to multiple spots along the
whole mitochondrial network (Figure 2(d)). These punctu-
ate structures containing Hfd1p were equally observed
after activation of mitochondrial biogenesis upon growth
on galactose medium.
If intracellular hexadecenal levels triggered mitochon-
drial dysfunction and oxidative stress, then genetic manipu-
lations of the sphingosine 1-phosphate metabolic pathway,
which favor the accumulation of hexadecenal, should aﬀect
cell viability. To test this hypothesis, we conditionally overex-
pressed the hexadecenal-generating enzyme Dpl1p in wild-
type and hfd1Δ cells. While the Dpl1p gain of function did
not lead to any growth phenotype in a wild type, it inhibited
growth in the hfd1Δ mutant (Figure 2(e)) accompanied by
ROS overproduction (Figure 2(f)), and this inhibition was
further increased upon mitochondrial damage caused by
valinomycin. Additionally, mitochondria are slightly more
fragmented in a hfd1Δ background alone, while mito-
chondrial fragmentation is further increased after Dpl1p
overexpression (Figure 2(g)). Thus, modulation of sphin-
golipid metabolism, and in particular the hexadecenal
intermediate, seemed to regulate mitochondrial function
and cell growth.
3.2. Hexadecenal Is the Main Inducer of Mitochondrial
Dysfunction and Fragmentation. The eﬀect of hexadecenal
on cell growth was tested directly by external addition to
yeast cells. As shown in Figure 3(a), hexadecenal strongly
inhibited cell growth in wild-type cells, which was slightly
exacerbated by oxidative stress or mitochondrial damage.
Hfd1p is important to counteract hexadecenal toxicity, which
is demonstrated by the hypersensitivity of hfd1Δ cells to hex-
adecenal (Figure 3(a)). Downstream metabolites such as hex-
adecenoic or palmitic acid did not cause growth inhibition
demonstrating the speciﬁcity of hexadecenal. The upstream
metabolites sphingosine-1-P or dihydrosphingosine-1-P
inhibited growth in a signiﬁcantly weaker manner indepen-
dently of the downstream enzymatic activities of Dpl1p and
Hfd1p (Figure 3(a)). Thus, within the S1-P degradation path-
way, hexadecenal is the most biologically active metabolite.
Accordingly, hexadecenal treatment rapidly induced mito-
chondrial fragmentation preferentially in glucose-grown
cells. A fully developed mitochondrial network upon respira-
tory growth seemed to protect from hexadecenal-induced
fragmentation in wild-type cells, but not in the hfd1 mutant
(Figure 3(b)). Additionally, galactose growth counteracted
hexadecenal-induced growth inhibition, which was still
observed in hfd1Δ mutants (Figure 3(c)).
We further found that the hexadecenal-induced mito-
chondrial fragmentation depended on the Dnm1p GTPase
and not the Fis1p ﬁssion protein (Figure 3(d)). However,
mitochondrial ﬁssion is not the reason for hexadecenal-
triggered cell death, because the dnm1Δ strain was even more
sensitive to the fatty aldehyde than wild-type cells
(Figure 3(e)). Taken together, hexadecenal eﬃciently triggers
cell death in yeast cells, which is not causally linked to
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Figure 1: Stress-induced expression of genes encoding outer mitochondrial membrane proteins. (a) Reverse transcriptase determination of
mRNA induction of four outer mitochondrial membrane protein encoding genes upon salt shock (0.4M NaCl) and oxidative stress (50 μM
menadione) for the indicated times. The GRE2 gene was included as a positive marker for salt and oxidative stress. Data are presented as
mean± SD. Three biological replicates were analyzed. The mRNA level was normalized in all cases for the ACT1 control, and the
uninduced level was arbitrarily set to 1. (b) Representation of consensus binding sites for stress-activated transcription factors in the
promoter regions of OM14, RDL1, MCR1, and HFD1. (c) Reverse transcriptase determination of mRNA induction of the same genes in
the indicated strain backgrounds upon salt shock (0.4M NaCl) as described in (a). Signiﬁcantly diﬀerent mRNA levels as compared to wt
are marked. ∗P < 0 05; ∗∗P < 0 01 (Student’s t-test). (d) Reactive oxygen species (ROS) production in mutants aﬀected in speciﬁc
mitochondrial outer membrane proteins. 2′,7′-dichlorodihydroﬂuorescein diacetate assay in the indicated yeast strains before or after salt
(1M NaCl, 2 h) or oxidative shock (50 μM menadione, 2 h). Data are presented as mean± SD. Three biological replicates were analyzed.
Signiﬁcantly diﬀerent ROS levels as compared to wt are marked. ∗P < 0 05; ∗∗P < 0 01 (Student’s t-test).
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Figure 2: Continued.
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mitochondrial fragmentation. Accordingly, although mito-
chondrial fragmentation generally accompanies apoptosis
in diﬀerent cellular models, it is not a prerequisite for cell
death [40]. In mammalian cells, the Drp1 ﬁssion protein is
responsible for apoptotic mitochondrial fragmentation, but
similarly to what is reported here for yeast, its function in
mitochondrial ﬁssion is not decisive for MOMP and subse-
quent cell death [41, 42].
3.3. Modulation of Sphingolipid Metabolism Triggers
Mitochondrial Cell Death in Yeast. We next wanted to test
whether the sphingolipid degradation pathway and especially
the hexadecenal intermediate triggered cell death via the
mitochondrial death pathway. In higher eukaryotes, mito-
chondrial apoptosis is irreversibly induced by the perme-
abilization of the outer mitochondrial membrane. This
process is highly controlled by pro- and antiapoptotic mem-
bers of the Bcl-2 family. In yeast, only one Bcl-2 ortholog has
been identiﬁed, Ybh3p, which has both pro- and antiapopto-
tic properties [33, 43]. We tested whether Ybh3p was func-
tionally involved in hexadecenal-mediated growth arrest. As
expected, Ybh3p translocated to mitochondria upon the apo-
ptotic stimulus of acetic acid treatment. However, hexadece-
nal treatment did not induce mitochondrial localization of
Ybh3p (Figure 4(a)). Additionally, the lack of Ybh3p
function did not change the susceptibility of yeast cells to
externally added hexadecenal (Figure 4(b)). Ybh3p is there-
fore not the executor of hexadecenal-induced cell death.
Alternatively, we examined the death-promoting and
death-preventing functions of human Bcl-2 members in
yeast cells with an altered sphingolipid metabolism. Human
Bax protein has been shown to eﬃciently activate mitochon-
drial cell death in yeast [25, 44]. Here, we found that the
induced Bax expression arrested cell growth in a synergistic
manner with external hexadecenal (Figure 5(a)). On the
other hand, antiapoptotic human Bcl-xL expression largely
prevented hexadecenal-induced growth inhibition. Thus,
hexadecenal seemed to arrest cell growth via proteins of the
Bcl-2 family when expressed ectopically in yeast. This was
further supported by the fact that Bax was a more eﬃcient
inhibitor in cells with a block in the hexadecenal-
metabolizing Hfd1p enzyme (Figure 5(b)). Thus, Bcl-2 pro-
teins such as Bax promote growth arrest in yeast cells in a
process, which is modulated by sphingolipid degradation
products such as hexadecenal. Our results support the idea
that high mitochondrial hexadecenal levels would favor the
proapoptotic action of Bax and subsequently promote mito-
chondrial fragmentation. In this model, the Hfd1p enzyme
would counteract hexadecenal accumulation at mitochon-
dria and prevent the induction of cell death. It remains to
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Figure 2: Sphingolipid degradation modulates mitochondrial activity in yeast. (a) Schematic overview of the enzymatic conversions of
sphingolipid degradation. Downstream enzymatic activities of dihydrosphingosine-1-phosphate are depicted. Only the conversions of
dihydrosphingosine and not of other sphingosine species such as phytosphingosine are shown. (b) Oxygen consumption rates of mutants
aﬀected in the sphingolipid degradation pathway. Cells were grown in synthetic galactose medium. The fzo1Δ mutant was included as a
negative control. The O2 consumption rate of the wild type was arbitrarily set to 1. (c) Reactive oxygen species (ROS) production in
mutants aﬀected in hexadecenal production (dpl1Δ) or degradation (hfd1Δ). 2′,7′-dichlorodihydroﬂuorescein diacetate assay in the
indicated yeast strains before or after salt shock (1M NaCl, 2 h). ROS levels upon normal growth conditions were set to 1 for each strain
background. (d) Intracellular localization of Hfd1p. Cells expressing constitutive Hfd1-GFP and Om14-dsRed fusion proteins were grown
in synthetic glucose- or galactose-containing medium. (e, f) Genetic manipulation of the sphingolipid degradation pathway aﬀects cell
viability and ROS production. The hexadecenal-producing Dpl1p enzyme was overexpressed under control of the GAL1 promoter in yeast
wild type or the hfd1Δ mutant. (e) Growth eﬃciency was assessed on synthetic agar medium-containing glucose (SD) or galactose (SGal)
supplemented or not with 4 μM valinomycin. Alternatively, colony formation was quantiﬁed in the same strains (lower panel). Cells from
fresh overnight cultures in synthetic glucose medium were diluted in the indicated media to an OD600 of 0.1, and growth was allowed for
an additional 24 h. Colony-forming units were determined by plating the cells onto YPD agar medium. The colony number obtained for
the wt upon the diﬀerent growth conditions was set to 100. (f) Quantiﬁcation of ROS production in the same strains grown in synthetic
glucose or galactose medium by the 2′,7′-dichlorodihydroﬂuorescein diacetate assay. (g) Overexpression of Dpl1p causes mitochondrial
fragmentation in hfd1Δ mutants. MitoTracker-stained mitochondria were visualized in the indicated yeast cells containing the empty
vector or the galactose-inducible DPL1 expression on synthetic galactose medium. Data information: in (b, c, e, and f), data are presented
as mean± SD. Three biological replicates were analyzed. Signiﬁcant changes with respect to the wild type are marked. ∗P < 0 05,
∗∗P < 0 01 (Student’s t-test).
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Figure 3: Hexadecenal is the most biologically active intermediate of the sphingolipid degradation pathway. (a) Hexadecenal and the
downstream metabolites hexadecenoic and palmitic acid were tested for growth inhibition of the indicated yeast strains (left panel). The
indicated doses were applied for 2 h, and colony formation was subsequently assessed on YPD plates containing or not 50 μM menadione
or 4 μM valinomycin. The upstream metabolites sphingosine-1-phosphate (S1-P) and dihydrosphingosine-1-phosphate were tested for
growth inhibition of the indicated yeast strains in the right panel. (b) External hexadecenal addition causes mitochondrial fragmentation
dependent on Hfd1p function. Mitochondria were visualized by expression of mt-GFP in yeast wild type and the hfd1Δ mutant in
synthetic glucose or glycerol/ethanol medium before and after the exposure (1 h) to 50 μM hexadecenal. (c) Galactose growth counteracts
hexadecenal growth inhibition. Hexadecenal was applied for 1 h to the indicated yeast strains grown on glucose- or galactose-containing
synthetic medium. Colony formation was then assessed on YPD agar plates. (d) Hexadecenal induces mitochondrial fragmentation
through Dnm1p. The indicated yeast strains expressing mt-GFP were treated or not with 50μM hexadecenal for 1 h before visualization of
mitochondria. (e) Suppression of mitochondrial ﬁssion does not counteract hexadecenal-mediated growth inhibition. The indicated yeast
strains were assayed for hexadecenal inhibition as in (a).
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be experimentally addressed whether changes in hexadecenal
metabolism trigger mitochondrial outer membrane perme-
abilization in yeast.
As Hfd1p localizes to speciﬁc sites along mitochon-
dria and the metabolism of complex sphingolipids occurs
at the endoplasmic reticulum, we tested whether ER-
mitochondrial contacts were involved in the hexadecenal-
mediated cell death. The ER-mitochondria encounter
structure (ERMES), which tethers mitochondria to the ER at
strategic sites [45], has been implied in the transfer of phos-
pholipids from theER tomitochondria [46].However, a direct
role of ERMES in lipid transfer between the two organelles is
still a matter of debate [47]. We found that Hfd1p often local-
izes in close vicinity to the ERMES subunit Mmm1p
(Figure 6(a)). Moreover, the distribution of Hfd1p in small
spots along mitochondria is disrupted in several ERMES
mutants, and an aberrant distribution of Hfd1p in very few
enlarged structures was observed (Figure 6(b)). Thus,
ERMES might be involved in the distribution of hexadecenal
along mitochondria and condition the localization of the
Hfd1p enzyme. Furthermore, we conﬁrmed that hexadecenal
toxicity is enhanced in ERMES mutants (Figure 6(c)), which
suggests that a normal Hfd1p distribution at mitochondria
might be necessary to eﬃciently counteract hexadecenal-
induced growth arrest. Of note, ER-mitochondria contacts
are also marks for mitochondrial ﬁssion mediated by
Dnm1p [48], and ERMES has been implied in this process
[49]. Thus, a regulated transfer of hexadecenal from the ER
to mitochondria at speciﬁc tethers could locally induce
fragmentation of the organelle.
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Figure 4: Yeast Ybh3p is not involved in hexadecenal-mediated cell death. (a) Mitochondrial association of Ybh3p is stimulated by acetic
acid, but not by hexadecenal. Intracellular localization relative to the MitoTracker-stained mitochondria of a Ybh3-GFP fusion protein
expressed in wild type was observed upon acetic acid (100mM, 1 h at pH 3.0) or hexadecenal (50 μM, 1 h) treatment. (b) Sensitivity to
hexadecenal is not altered in ybh3Δ mutants. The growth eﬃciency upon external addition of hexadecenal was assayed as in Figure 3(a) in
wild type and ybh3Δ mutants.
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3.4. Genetic Control of the Sphingolipid Degradation Pathway
via the Hog1p MAP Kinase. The expression of theHFD1 gene
is activated by salt and oxidative stress. Thus, we tested
whether the expression of genes encoding the enzymes of
sphingolipid degradation was generally regulated by stress
(Figure 7(a)). We found that all enzymatic steps from cer-
amide to hexadecenoic acid were inducible by NaCl stress
at the mRNA level (Figure 7(b)). Moreover, the Hog1p
stress-activated kinase, which is the key regulator of the
adaptive response of yeast to osmotic stress [50], was
indispensable for this transcriptional activation. In turn,
most of the reverse enzymatic reactions from S1-P to cer-
amide were transcriptionally repressed under the same
conditions (Figure 7(c)). Thus, yeast cells employ a genetic
regulation, which seems to favor the degradation of sphin-
golipids over its biosynthesis upon stress. This switch is
controlled by the Hog1p MAP kinase, which could
therefore be a modulator of sphingolipid metabolic inter-
mediates during exposure to salt stress. Accordingly, we
found that hog1Δ mutants were more sensitive to external
hexadecenal (Figure 7(d)), which could be explained by a
decreased detoxiﬁcation capacity of this strain-lacking
Hfd1p activation.
We further investigated the correlation between salt
stress, sphingolipid metabolism, and mitochondrial function.
As salt stress induced the genes encoding sphingolipid-
metabolizing enzymes, a block after hexadecenal formation
could be deleterious especially upon NaCl stress. We found
indeed that hfd1Δ mutant cells showed complete mitochon-
drial fragmentation upon salt shock, which was not observed
in the wild type (Figure 7(e)). Finally, we tested whether
Hog1p function was important for Bax toxicity. We found
that hog1Δ mutants were more resistant to Bax expression
than wild-type cells (Figure 7(f)). Taken together, the Hog1p
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Figure 5: Bax-mediated growth inhibition is modulated by hexadecenal levels. (a) External hexadecenal potentiates Bax function. Human
proapoptotic Bax and antiapoptotic Bcl-xL were expressed under control of the Tetoﬀ promoter for the indicated times in the presence or
not of the indicated hexadecenal concentrations. Control strains contained the respective empty vectors. Colony formation was then
assessed on YPD agar plates. (b) Bax inhibition is enhanced in hfd1Δ mutants. Human Bax expression was induced for 24 h in the
indicated yeast strains by the removal of doxycycline.
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stress-activated kinase is involved in the induction of sphin-
golipid metabolic enzymes and this activation could lead to
the accumulation of bioactive intermediates, especially hexa-
decenal, at mitochondria. In the absence of detoxiﬁcation by
the Hfd1p enzyme, this can induce the mitochondrial death
pathway by favoring the activity of proapoptotic proteins such
asBax.Ofnote, hyperosmotic andNaCl stress are knownenvi-
ronmental conditions, which induce mitochondria-mediated
cell death in yeast [51, 52]. In this scenario, stress-activated
Hog1p could trigger mitochondrial dysfunction by activating
sphingolipid degradation. This model is in agreement with
the previous ﬁnding that sustained activation of Hog1p
impairsmitochondrial respiration, increases ROSproduction,
and induces cell death [53].
It is important to note that the sphingolipid metabolite
hexadecenal also inhibits mitochondrial function in higher
eukaryotes. Hexadecenal addition to murine mitochondria
eﬃciently permeabilizes the outer membrane [17], which
has been postulated as an early irreversible decision to
enter the mitochondria-mediated death pathway [19].
Accordingly, hexadecenal is a potent activator of apoptosis
in mouse and human cell lines [18].
4. Conclusions
Our work suggests that the modulation of mitochondrial
activity and induction of cell death by hexadecenal are a
conserved feature of eukaryotic cells. However, apart from
its proapoptotic function when externally applied to cells or
mitochondria, it was not known whether intracellular regula-
tion of hexadecenal metabolism was involved in modulating
mitochondrial function and death. Importantly, we show
here that the regulation of the sphingolipid degradation path-
way is a decisive trigger of mitochondrial function and cell
growth in yeast. Hexadecenal is the intermediate in this path-
way with the highest impact on mitochondrial function.
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Figure 6: Functional connection between the ERMES complex and hexadecenal-mediated cell death. (a) Colocalization study of Hfd1-GFP
with the Mmm1-mCherry ERMES complex subunit. Cells were grown in synthetic galactose medium for the induced expression of the
Mmm1-mCherry fusion. (b) Intracellular distribution of Hfd1p is aﬀected in ERMES complex mutants. Hfd1-GFP was expressed in the
indicated yeast strains and localized relative to MitoTracker-stained mitochondria. Cells were grown in synthetic glucose medium. (c)
ERMES complex mutants are hypersensitive to hexadecenal. The growth eﬃciency upon external addition of hexadecenal (HD) was
assayed as in Figure 3(a) in wild type and the indicated ERMES deletion mutants (upper panel). Quantitative colony assays are shown for
the same strains in the lower panel. Cells from fresh overnight cultures in synthetic glucose medium were diluted to OD600 0.5 and then
incubated with the indicated hexadecenal doses for 2 h. Colony-forming units were determined by plating the cells onto YPD agar
medium. Data are presented as mean± SD. Three biological replicates were analyzed. The colony number obtained for the wt upon
control conditions was set to 100. Signiﬁcant changes with respect to the wild type upon the same growth condition are marked.
∗P < 0 05, ∗∗P < 0 01 (Student’s t-test).
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Figure 7: Stress regulation of the sphingolipid degradation pathway via Hog1p and its impact on mitochondrial integrity. (a) Schematic
overview of the enzymatic conversions implied in sphingolipid biosynthesis and degradation in yeast. (b) Expression of sphingolipid
degradation enzymes is stimulated upon salt stress in a Hog1p-dependent manner. RT-PCR analysis of gene expression in the indicated
yeast strains upon salt shock (0.4M NaCl, 20min). Relative mRNA levels of the indicated genes were normalized for the ACT1 control.
(c) Expression of sphingolipid biosynthesis enzymes is generally repressed upon salt stress. Yeast wild-type cells were analyzed by RT-PCR
as in (b). In (b, c), data are presented as mean± SD. Three biological replicates were analyzed. Signiﬁcant changes with respect to the wild
type (b) or to the nonstress condition (c) are marked. ∗P < 0 05; ∗∗P < 0 01 (Student’s t-test). (d) Loss of Hog1p function causes
hexadecenal sensitivity. Growth inhibition of the indicated yeast strains by hexadecenal was assessed as in Figure 3(a). (e) Salt stress
induces mitochondrial fragmentation in hfd1Δ mutant cells. Yeast cells expressing mt-GFP on synthetic glucose medium were treated or
not with 1M NaCl before visualization of mitochondria. (f) Loss of Hog1p function counteracts Bax inhibition. Human Bax expression
was induced for 24 h as in Figure 5(b) in wild type and hog1Δ mutants. Growth was then recorded on YPD agar plates.
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Genetic interventions, which favor intracellular hexadecenal
production, induce ROS imbalance, decrease respiration,
and arrest cell growth. Moreover, stress-activated signaling
pathways, such as HOG, are implied in the regulation of
sphingolipid degradation, which in turn can be decisive for
the entry into cell death pathways upon environmental stress.
Mutations in the ALDH3A2 gene, encoding the human
ortholog of yeast Hfd1p fatty aldehyde dehydrogenase, cause
Sjögren-Larsson syndrome, a rare neurocutaneous disorder
[54]. In the light of our results, the implication of the accu-
mulation of toxic fatty aldehydes and their eﬀect on mito-
chondrial function should be further investigated in human
cells with impaired ALDH3A2 enzymatic activity.
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